Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Calcium-activated K(Ca)1.1 potassium channel activator shows promise in model of bladder dysfunction

Nov. 10, 2011

Daiichi Sankyo gains Brazilian rights to drug for overactive bladder

Nov. 8, 2011

Protox Therapeutics' study of transrectal PRX-302 advances

Oct. 21, 2011

U.S. universities assess CDME in model of cystinuria

Oct. 19, 2011

Researchers at Astellas synthesize new serotonin 5-HT2C receptor agonists

Oct. 13, 2011

FDA approves Lilly's Cialis for new indications

Oct. 7, 2011

Ampio Pharmaceuticals announces promising data from Zertane extension study

Sep. 29, 2011

Keryx Biopharmaceuticals completes enrollment in long-term Zerenex trial

Sep. 20, 2011

Astellas Pharma set to launch Betanis in Japan

Sep. 15, 2011

Thrasos Innovation advances THR-184 to clinic

Sep. 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...